Cataracts after autologous bone marrow transplantation in children

P Frisk1, H Hagberg, A Mandahl

  • 1Uppsala University Children's Hospital, Sweden.

Insights

Total body irradiation (TBI) significantly increases posterior subcapsular cataract (PSC) risk in pediatric bone marrow transplant (BMT) patients. High PSC incidence necessitates monitoring, especially after TBI-based conditioning regimens.

Area of Science:

  • Ophthalmology
  • Hematology
  • Oncology

Background:

  • Pediatric bone marrow transplantation (BMT) is a crucial treatment for hematologic and lymphoid malignancies.
  • Cataract development, particularly posterior subcapsular cataract (PSC), is a known complication following BMT.
  • Understanding risk factors for PSC is vital for long-term patient care.

Purpose of the Study:

  • To determine the incidence and severity of PSC in children undergoing autologous or syngeneic BMT.
  • To investigate the role of total body irradiation (TBI) and other pre-transplant therapies in PSC development.
  • To assess the impact of PSC on visual acuity and the need for surgical intervention.

Main Methods:

  • Retrospective analysis of 29 children post-BMT (autologous or syngeneic).
  • Assessment of PSC incidence and degree, correlated with conditioning regimens (chemotherapy +/- TBI) and prior cranial irradiation.
  • Follow-up for 4-10 years to evaluate visual acuity and need for cataract surgery.

Main Results:

  • 22 out of 29 patients developed PSC within 4 years post-BMT.
  • All patients receiving TBI (n=21) developed PSC, with 38% experiencing significant visual impairment (<0.8 acuity).
  • Six patients required cataract surgery; TBI was identified as the primary cause of PSC.

Conclusions:

  • Autologous BMT conditioning regimens including TBI are associated with a high incidence of PSC in pediatric patients.
  • TBI is the main etiological factor for PSC development in this cohort.
  • Close ophthalmologic monitoring is recommended for pediatric BMT survivors, especially those who received TBI.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...